The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Five-year follow-up update of defined-composition CD19 CAR T-cell therapy for relapsed/refractory CLL.
 
Emily C. Liang
Employment - Meissa Vaccines (I)
 
Alexandre V. Hirayama
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Juno Therapeutics; Nektar
 
Erik Lesley Kimble
Research Funding - Juno Therapeutics
 
Andrew Jay Portuguese
No Relationships to Disclose
 
Aya Albittar
No Relationships to Disclose
 
Aude Chapuis
Stock and Other Ownership Interests - Adaptive Biotechnologies; Affini-T Therapeutics; Metagenomi; SignalOne Bio; TScan Therapeutics
Consulting or Advisory Role - Affini-T Therapeutics; BioNTech; Metagenomi; Ridgeline Discovery; SignalOne Bio; TScan Therapeutics
Patents, Royalties, Other Intellectual Property - Adaptive Biotechnologies; Affini-T Therapeutics; Amazon.com; Celgene; Cullinan Oncology; ElevateBio; Lonza Walkersville
 
Mazyar Shadman
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Abbvie; Adaptimmune; Adaptive Biotechnologies; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Cellectar; Epizyme; Fate therapeutics; Genentech; Innate Pharma; Kite, a Gilead company; Lilly; MEI Pharma; MorphoSys; MustangBio; Pharmacyclics; Regeneron; Sound Biologics; TG Therapeutics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene; Celgene (Inst); Genentech (Inst); Genmab (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst); Vincerx Pharma (Inst)
 
Brian G. Till
Stock and Other Ownership Interests - Proteios Technology
Consulting or Advisory Role - MustangBio; Proteios Technology
Research Funding - Bristol-Myers Squibb/Celgene/Juno; MustangBio (Inst)
Patents, Royalties, Other Intellectual Property - Patent and royalties for a CD20-targeted chimeric antigen receptor from Mustang Bio
 
Ryan Daniel Cassaday
Employment - Seagen (I)
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Kite, a Gilead company; Pfizer
Consulting or Advisory Role - Amgen; Jazz Pharmaceuticals; Kite/Gilead; Pfizer
Research Funding - Amgen (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Pfizer; SERVIER (Inst); Vanda Pharmaceuticals
Travel, Accommodations, Expenses - Kite, a Gilead company
Other Relationship - Autolus; Pepromene
 
Filippo Milano
No Relationships to Disclose
 
Cameron John Turtle
Stock and Other Ownership Interests - ArsenalBio; Caribou Biosciences; Eureka Therapeutics; Myeloid Therapeutics; Precision Biosciences
Consulting or Advisory Role - Alimera Sciences; Amgen; ArsenalBio; Asher Biotherapeutics; Caribou Biosciences; Century Therapeutics; Genentech; GlaxoSmithKline; Myeloid Therapeutics; Precision Biosciences; T-CURX
Research Funding - AstraZeneca/MedImmune; Juno Therapeutics; Nektar
Patents, Royalties, Other Intellectual Property - Three patents licensed or pending.
 
David G. Maloney
Leadership - A2 Biotherapeutics; Bristol-Myers Squibb; Chimeric Therapeutics; Genentech; Gilead Sciences; ImmPACT Bio; Interius Biotherapeutics; NAVAN Technologies
Stock and Other Ownership Interests - A2 Biotherapeutics; NAVAN Technologies
Consulting or Advisory Role - Bristol-Myers Squibb; Caribou Biosciences; Celgene; Genentech; Incyte; Juno Therapeutics; Kite, a Gilead Company; Lilly O.
Research Funding - Celgene; Juno Therapeutics; Kite, a Gilead Company; Legend Biotech
Patents, Royalties, Other Intellectual Property - DGM has the rights to royalties from Fred Hutch for patents licensed to Juno Therapeutics/BMS
 
Jordan Gauthier
Consulting or Advisory Role - Janssen; Kite, a Gilead Company; Legend Biotech; MorphoSys; Sobi
Research Funding - Angiocrine Bioscience; Celgene; Juno Therapeutics; Sobi